Some evidences have shown that signaling pathway that steer resistance to therapeutic treatment can intersect with the signaling of cell invasion, but the shared mechanisms still need to be fully discovered including in EGFR-TKIs resistance-induced tumor progression [11]. This evidence concerns the gene EGFR and neoplasm.